About NetScientific

NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.

NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.

NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.

An entrepreneur-led senior management team with extensive biomedical, healthcare and commercial experience.

  • Sir Richard Sykes FRS

  • François Martelet M.D.

  • Michael Boyce-Jacino PhD

  • David Gough MBA

  • Peter Thoms FCA

  • Vijay Barathan M.D.

Our Portfolio

  • Digital Health
  • Diagnostics
  • Therapeutics

Unique Partnership Model

The partnership with Breakout Labs provides NetScientific and its investors with access to some of the most revolutionary new technologies coming out of Silicon Valley and beyond.


Latest News

RNS Announcements

  • 16-11-2015 – Issue of Equity >>
  • 11-11-2015 – Holding(s) in Company >>
  • 10-11-2015 – Grant of Options >>
  • 06-11-2015 – Result of General Meeting >>
  • 06-11-2015 – Result of Placing and Further Allotment of Shares >>
  • 03-11-2015 – Holding(s) in Company >>

NetScientific Portfolio News

News from Vortex BioSciences

  • Meet our collaborators at MicroTAS 2015 – October 25-29, 2015 in Gyeongju, KOREA

    2015-10-09 03:59

  • Prof. Dino Di Carlo is the winner of the 2015 “Pioneers of Miniaturization” Lectureship

    2015-10-09 02:47

  • Vortex Biosciences featured in Labiotech Tour

    2015-09-22 09:02


News from ProAxsis

News from Glycotest

  • NetScientific’s subsidiary, Glycotest Begins a New Research Collaboration with Oncimmune

    2014-10-03 11:14